---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-019651"
form_type: "8-K"
ticker: "INTI"
cik: "0001042418"
company_name: "Inhibitor Therapeutics, Inc."
filed_at: "2023-05-31T23:59:59+00:00"
generated_at: "2026-06-14T10:10:08.462729+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Michelle Yanez resigns; Michael Jerman appointed to Inhibitor Therapeutics Board

## Summary
- Michelle Yanez resigned from the Board effective May 24, 2023, to take a full-time CFO role elsewhere; no disagreement with the company.
- Michael Jerman, CPA, appointed as independent director and Chairman of the Audit Committee, effective May 24, 2023.
- Jerman brings experience as CFO of private equity-backed companies, former PwC director, and USAF captain; deemed a financial expert.

## SEC filing metadata
- accession: 0001493152-23-019651
- form_type: 8-K
- ticker: INTI
- cik: 0001042418
- company_name: Inhibitor Therapeutics, Inc.
- filed_at: 2023-05-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1042418/000149315223019651/0001493152-23-019651-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1042418/000149315223019651/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-019651
- JSON: https://secwatch.observer/filing/0001493152-23-019651.json
- Plain text: https://secwatch.observer/filing/0001493152-23-019651.txt

## Key facts
- Executive change
  Michael Jerman was appointed as Director at Inhibitor Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: On May 24, 2023, the Board of the Company appointed Michael Jerman, CPA. as an independent member of its Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1042418/000149315223019651/0001493152-23-019651-index.htm
- Executive change
  Michelle Yanez resigned as Director at Inhibitor Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On and effective May 24, 2023, Michelle Yanez gave notice to Inhibitor Therapeutics, Inc. (the “Company”) of her resignation from the Board of Directors of the Company (the “Board”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1042418/000149315223019651/0001493152-23-019651-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.